January 2024 Dr Deeren discusses the latest update in the management of patients with Paroxysmal Nocturnal Hemoglobinuria including the place of the new long acting C5 inhibitor ravulizumab in the treatment algorithm Dr. Dries Deeren (AZ Delta, Roeselare) This HematoTalk is brought to you by the publisher of the Belgian Journal of Hematology in partnership with Alexion.BE/ULT-P/0025 – January 2024. SUBSCRIBE TO BJH HEMATALKS SERIES
Top
